151 related articles for article (PubMed ID: 12609847)
1. Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain.
Odeberg J; Plachter B; Brandén L; Söderberg-Nauclér C
Blood; 2003 Jun; 101(12):4870-7. PubMed ID: 12609847
[TBL] [Abstract][Full Text] [Related]
2. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway.
Miller DM; Rahill BM; Boss JM; Lairmore MD; Durbin JE; Waldman JW; Sedmak DD
J Exp Med; 1998 Mar; 187(5):675-83. PubMed ID: 9480977
[TBL] [Abstract][Full Text] [Related]
3. Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING.
Biolatti M; Dell'Oste V; Pautasso S; Gugliesi F; von Einem J; Krapp C; Jakobsen MR; Borgogna C; Gariglio M; De Andrea M; Landolfo S
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263269
[TBL] [Abstract][Full Text] [Related]
4. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
Tabi Z; Moutaftsi M; Borysiewicz LK
J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
[TBL] [Abstract][Full Text] [Related]
5. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
[TBL] [Abstract][Full Text] [Related]
7. The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture.
Schmolke S; Kern HF; Drescher P; Jahn G; Plachter B
J Virol; 1995 Oct; 69(10):5959-68. PubMed ID: 7666500
[TBL] [Abstract][Full Text] [Related]
8. Human cytomegalovirus disrupts constitutive MHC class II expression.
Cebulla CM; Miller DM; Zhang Y; Rahill BM; Zimmerman P; Robinson JM; Sedmak DD
J Immunol; 2002 Jul; 169(1):167-76. PubMed ID: 12077242
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell-induced apoptosis of human cytomegalovirus-infected fibroblasts promotes cross-presentation of pp65 to CD8+ T cells.
Mandron M; Martin H; Bonjean B; Lulé J; Tartour E; Davrinche C
J Gen Virol; 2008 Jan; 89(Pt 1):78-86. PubMed ID: 18089731
[TBL] [Abstract][Full Text] [Related]
10. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
[TBL] [Abstract][Full Text] [Related]
11. Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells.
Arrode G; Boccaccio C; Lulé J; Allart S; Moinard N; Abastado JP; Alam A; Davrinche C
J Virol; 2000 Nov; 74(21):10018-24. PubMed ID: 11024130
[TBL] [Abstract][Full Text] [Related]
12. Three T-cell epitopes within the C-terminal 265 amino acids of the matrix protein pp65 of human cytomegalovirus recognized by human lymphocytes.
Khattab BA; Lindenmaier W; Frank R; Link H
J Med Virol; 1997 May; 52(1):68-76. PubMed ID: 9131460
[TBL] [Abstract][Full Text] [Related]
13. Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.
Sandhu PK; Buchkovich NJ
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915281
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus- and interferon-related effects on human endothelial cells. Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-gamma.
Scholz M; Hamann A; Blaheta RA; Auth MK; Encke A; Markus BH
Hum Immunol; 1992 Dec; 35(4):230-8. PubMed ID: 1284062
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
Johnson DC; Hegde NR
Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
[TBL] [Abstract][Full Text] [Related]
16. Modulation of major histocompatibility class II protein expression by varicella-zoster virus.
Abendroth A; Slobedman B; Lee E; Mellins E; Wallace M; Arvin AM
J Virol; 2000 Feb; 74(4):1900-7. PubMed ID: 10644363
[TBL] [Abstract][Full Text] [Related]
17. Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells.
Arrode G; Boccaccio C; Abastado JP; Davrinche C
J Virol; 2002 Jan; 76(1):142-50. PubMed ID: 11739680
[TBL] [Abstract][Full Text] [Related]
18. Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression.
Le Roy E; Mühlethaler-Mottet A; Davrinche C; Mach B; Davignon JL
J Virol; 1999 Aug; 73(8):6582-9. PubMed ID: 10400755
[TBL] [Abstract][Full Text] [Related]
19. Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response.
Retière C; Prod'homme V; Imbert-Marcille BM; Bonneville M; Vié H; Hallet MM
J Virol; 2000 May; 74(9):3948-52. PubMed ID: 10756006
[TBL] [Abstract][Full Text] [Related]
20. Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice.
Lenfant F; Pizzato N; Liang S; Davrinche C; Le Bouteiller P; Horuzsko A
J Gen Virol; 2003 Feb; 84(Pt 2):307-317. PubMed ID: 12560562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
